Previous research has revealed that the Apolipoprotein-ε4 (APOE-ε4) allele increases the risk for a variety of diseases in aging populations, specifically Alzheimer’s and cardiovascular disease.
Avalo fails asthma PhII with lead candidate, shares crater
Avalo Therapeutics, a biotech working on immunology, said its lead candidate failed a Phase II study testing the treatment in a specific type of asthma